Daver, N., Ikezoe, T., Watts, J., Hosono, N., Ogawa, Y., Miyazaki, Y., … Yuda, J. (2023). P38-8 Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation. In Annals of Oncology (Vol. 34, pp. S1456–S1456). Elsevier BV. https://doi.org/10.1016/j.annonc.2023.09.383

Daver, Naval, Takayuki Ikezoe, Justin Watts, Naoko Hosono, Yoshiaki Ogawa, Yasushi Miyazaki, Harry Erba, et al. “P38-8 Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation.” In Annals of Oncology, 34:S1456–S1456. Elsevier BV, 2023. https://doi.org/10.1016/j.annonc.2023.09.383.

Daver N, Ikezoe T, Watts J, Hosono N, Ogawa Y, Miyazaki Y, et al. P38-8 Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation. In: Annals of Oncology. Elsevier BV; 2023. p. S1456–S1456.

Daver, Naval, et al. “P38-8 Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation.” Annals of Oncology, vol. 34, Elsevier BV, 2023, pp. S1456–S1456. Crossref, doi:10.1016/j.annonc.2023.09.383.

Daver N, Ikezoe T, Watts J, Hosono N, Ogawa Y, Miyazaki Y, Erba H, Affinito J, Cai H, Brooks E, Eguchi K, Stoudemire J, Watanabe A, Kuwaki T, Hitron M, Komarnitsky P, Yuda J. P38-8 Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation. Annals of Oncology. Elsevier BV; 2023. p. S1456–S1456.